المؤلفون: Angelika V. Timofeeva, Ivan S. Fedorov, Aleksandra V. Asaturova, Maya V. Sannikova, Anna V. Tregubova, Oleg A. Mayboroda, Grigory N. Khabas, Vladimir E. Frankevich, Gennady T. Sukhikh

المصدر: International Journal of Molecular Sciences; Volume 24; Issue 15; Pages: 12214

مصطلحات موضوعية: miRNA, piRNA, mRNA, CA125, progesterone receptor (PGR), new-generation sequencing (NGS), quantitative RT-PCR, serous ovarian carcinoma, borderline cystadenoma, benign cystadenoma, formalin-fixed paraffin-embedded (FFPE) blocks, blood plasma, cytoreduction

جغرافية الموضوع: agris

وصف الملف: application/pdf

Relation: Molecular Genetics and Genomics; https://dx.doi.org/10.3390/ijms241512214

الاتاحة: https://doi.org/10.3390/ijms241512214

المؤلفون: M. S. Mosoyan, О. V. Kalinina, T. V. Vavilova, N. A. Aysina, A. V. Makeev, A. A. Borisov, М. С. Мосоян, О. В. Калинина, Т. В. Вавилова, Н. А. Айсина, В. А. Макеев, А. А. Борисов

المساهمون: Работа поддержана ФГБУ «НМИЦ им. В.А. Алмазова» Минздрава России.

المصدر: Translational Medicine; Том 10, № 4 (2023); 322-331 ; Трансляционная медицина; Том 10, № 4 (2023); 322-331 ; 2410-5155 ; 2311-4495

مصطلحات موضوعية: репарация ДНК, genetic testing, new generation sequencing (NGS), PARP, PCR, prostate cancer, гены-онкосупрессоры, гомологичная рекомбинация, мутация, рак предстательной железы

وصف الملف: application/pdf

Relation: https://transmed.almazovcentre.ru/jour/article/view/803/526; Маилян О.А., Калпинский А.С., Решетов И.В. и др. Определение распространенности мутаций в генах репарации ДНК в российской популяции у больных метастатическим кастрационно-резистентным раком предстательной железы. Онкоурология 2022;18(3):60–6]. DOI:10.17650/1726-97762022-18-3-60-66.; Злокачественные новообразования в России в 2020 году (заболеваемость и смертность). Под ред. А. Д. Каприна, В. В. Старинского, А. О. Шахзадовой. М.: МНИОИ им. П. А. Герцена — филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2021. 252 с.].; Налетов А.А., Недбайло С.А., Кудратова Е.А. и др. Применение апалутамида для лечения рака предстательной железы. Университетская медицина Урала. 2022. Том: 8 Номер: 2 (29). Страницы: 78–83. eLIBRARY ID: 49343196].; Leith A, Ribbands A, Kim J, et al. Real-world homologous recombination repair mutation testing in metastatic castration-resistant prostate cancer in the USA, Europe and Japan. Future Oncol. 2022; 18: 937–951. DOI:10.2217/fon-2021-1113.; Yoshida K, Miki Y. Role of BRCA1 and BRCA2 as regulators of DNA repair, transcription, and cell cycle in response to DNA damage. Cancer Sci. 2004; 95(11):866–871. DOI:10.1111/j.1349-7006.2004.tb02195.x; Samstein RM, Krishna C, Ma X, et al. Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy. Nat Cancer. 2021; 1(12):1188–1203. DOI:10.1038/s43018-020-00139-8.; Turnbull C, Sud A, Houlston RS. Cancer genetics, precision prevention and a call to action. Nat Genet. 2018; 50(9):1212–1218. DOI:10.1038/s41588-018-0202-0.; Логинова М.В., Павлов В.Н., Гилязова И.Р. Прогностическое значение мутаций в генах BRCA1 и BRCA2 при раке предстательной железы (обзор литературы). Креативная хирургия и онкология. 2021;11(2):183–187]. https://doi.org/10.24060/2076-30932021-11-2-183-187.; Cheng HH, Sokolova AO, Schaeffer EM, et al. Germline and Somatic Mutations in Prostate Cancer for the Clinician. J Natl Compr Canc Netw. 2019; 17(5):515–521. DOI:10.6004/jnccn.2019.7307.; Pritchard CC, Mateo J, Walsh MF, et al. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer. N Engl J Med. 2016; 375(5):443–453. DOI:10.1056/NEJMoa1603144.; Стукань А.И., Горяинова А.Ю., Григорян М.М. и др. Сигнальный механизм рецептора андрогена при раке предстательной железы: резистентность к антиандрогенной терапии и связь с генами репарации повреждений ДНК. Онкоурология 2023;19(1):85–101]. DOI:10.17650/17269776-2023-19-1-85-101.; Mai PL, Chatterjee N, Hartge P, et al. Potential excess mortality in BRCA1/2 mutation carriers beyond breast, ovarian, prostate, and pancreatic cancers, and melanoma. PLoS One. 2009; 4(3):e4812. DOI:10.1371/journal.pone.0004812.; Roy R, Chun J, Powell SN. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer. 2011; 12(1):68–78. DOI:10.1038/nrc3181.; Lin D, Izadpanah R, Braun SE, et al. A novel model to characterize structure and function of BRCA1. Cell Biol Int. 2018; 42(1):34–44. DOI:10.1002/cbin.10846.; Roy R, Chun J, Powell SN. BRCA1 and BRCA2: different roles in a common pathway of genome protection. Nat Rev Cancer. 2011 Dec 23;12(1):68–78. DOI:10.1038/nrc3181.; Castro E, Goh C, Leongamornlert D, et al. Effect of BRCA Mutations on Metastatic Relapse and Cause-specific Survival After Radical Treatment for Localised Prostate Cancer. Eur Urol. 2015; 68(2):186–193. DOI:10.1016/j.eururo.2014.10.022.; Song WH, Kim SH, Joung JY, et al. Prostate Cancer in a Patient with a Family History of BRCA Mutation: a Case Report and Literature Review. J Korean Med Sci. 2017; 32(2):377–381. DOI:10.3346/jkms.2017.32.2.377.; Castro E, Goh C, Olmos D, et al. Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer. J Clin Oncol. 2013; 31(14):1748–1757. DOI:10.1200/JCO.2012.43.1882.; Segal N, Ber Y, Benjaminov O, et al. Imaging-based prostate cancer screening among BRCA mutation carriersresults from the first round of screening. Ann Oncol. 2020; 31(11):1545–1552. DOI:10.1016/j.annonc.2020.06.025.; Ishiyama Y, Shimbo M, Iizuka J, et al. Association between prostate cancer characteristics and BRCA1/2associated family cancer history in a Japanese cohort. PLoS One. 2020; 15(12):e0244149. DOI:10.1371/journal.pone.0244149.; Ibrahim M, Yadav S, Ogunleye F, et al. Male BRCA mutation carriers: clinical characteristics and cancer spectrum. BMC Cancer. 2018; 18(1):179. DOI:10.1186/s12885-018-4098-y.; Abida W, Patnaik A, Campbell D, et al. Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration. J Clin Oncol. 2020; 38(32):3763–3772. DOI:10.1200/JCO.20.01035.; Mersch J, Jackson MA, Park M, et al. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer. 2015; 121(2):269–75. DOI:10.1002/cncr.29041.; Pellini F, Granuzzo E, Urbani S, et al. Male Breast Cancer: Surgical and Genetic Features and a Multidisciplinary Management Strategy. Breast Care (Basel). 2020; 15(1):14–20. DOI:10.1159/000501711.; Gallagher DJ, Gaudet MM, Pal P, et al. Germline BRCA mutations denote a clinicopathologic subset of prostate cancer. Clin Cancer Res. 2010; 16(7):2115–2121. DOI:10.1158/1078-0432.CCR-09-2871.; Mateo J, Boysen G, Barbieri CE, et al. DNA Repair in Prostate Cancer: Biology and Clinical Implications. Eur Urol. 2017; 71(3):417–425. DOI:10.1016/j.eururo.2016.08.037.; Stolarova L, Kleiblova P, Janatova M, et al. CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate. Cells. 2020; 9(12):2675. DOI:10.3390/cells9122675.; Zhen JT, Syed J, Nguyen KA, et al. Genetic testing for hereditary prostate cancer: Current status and limitations. Cancer. 2018; 124(15):3105–3117. DOI:10.1002/cncr.31316.; Dong X, Wang L, Taniguchi K, et al. Mutations in CHEK2 associated with prostate cancer risk. Am J Hum Genet. 2003; 72(2):270–280. DOI:10.1086/346094.; Матвеев В.Б., Киричек А.А., Савинкова А.В. и др. Влияние герминальных мутаций в гене CHEK2 на выживаемость до биохимического рецидива и безметастатическую выживаемость после радикального лечения у больных раком предстательной железы. Онкоурология 2018;14(4):53–67].; Wu S, Zhou J, Zhang K, et al. Molecular Mechanisms of PALB2 Function and Its Role in Breast Cancer Management. Front Oncol. 2020; 10:301. DOI:10.3389/fonc.2020.00301.; Голотюк М.А., Бережной А.А., Казанцева Н.В. и др. Герминальные мутации в генах PALB2 и CHEK2 и наследственный рак. Уральский медицинский журнал. 2023;22(3):126−136]. http://doi.org/10.52420/2071-5943-2023-22-3-126-136; Nicolosi P, Ledet E, Yang S, et al. Prevalence of germline variants in prostate cancer and implications for current genetic testing guidelines. JAMA Oncol. 2019;5(4):523−528. https://doi.org/10.1001/jamaoncol.2018.6760; Dillon KM, Bekele RT, Sztupinszki Z, et al. PALB2 or BARD1 loss confers homologous recombination deficiency and PARP inhibitor sensitivity in prostate cancer. NPJ Precis Oncol. 2022;6(1):49. https://doi.org/10.1038/s41698-022-00291-7.; Norris JD, Chang C-Y, Wittmann BM, et al. The homeodomain protein HOXB13 regulates the cellular response to androgens. Molec Cell. 2009;36(3):405−16. https://doi.org/10.1016/j.molcel.2009.10.020; Шашкин М.Н., Головко Д.А. Обзор универсальных и специфичных мутаций высокопенетрантных генов, ассоциированных с опухолями предстательной железы// Вестник науки. 2022. №6 (51)].; Рева С.А., Кудинова Н.И., Лапин С.В., Петров С.Б. Генетическое исследование как метод оценки предрасположенности к развитию рака предстательной железы. Вестник урологии. 2020;8(3):103−110]. https://doi.org/10.21886/2308-6424-2020-8-3-103-110; Park CK, Shin SJ, Cho YA, et al. HoxB13 expression in ductal type adenocarcinoma of prostate: clinicopathologic characteristics and its utility as potential diagnostic marker. Sci Rep. 2019;9(1):20205. https://doi.org/10.1038/s41598-019-56657-8.; Ueno S, Sudo T, Hirasawa A. ATM: Functions of ATM Kinase and Its Relevance to Hereditary Tumors. Int J Mol Sci. 2022; 23(1):523. DOI:10.3390/ijms23010523.; Neeb A, Herranz N, Arce-Gallego S, et al. Advanced Prostate Cancer with ATM Loss: PARP and ATR Inhibitors. Eur Urol. 2021; 79(2):200−211. DOI:10.1016/j.eururo.2020.10.029.; Zolotyh MA, Bilyalov AI, Nesterova AI, et al. Rak molochnoj zhelezy: genetika personal’nogo riska. Klinicheskaya onkologiya. 2023; 25(2): 190−198. In Russian [Золотых М.А., Билялов А.И., Нестерова А.И. и др. Рак молочной железы: генетика персонального риска. Клиническая онкология. 2023; 25(2): 190−198]. https://doi.org/10.26442/18151434.2023.2.202110; Kote-Jarai Z, Jugurnauth S, Mulholland S, et al. A recurrent truncating germline mutation in the BRIP1/FANCJ gene and susceptibility to prostate cancer. Br J Cancer 100, 426–430 (2009). https://doi.org/10.1038/sj.bjc.6604847; Isaacsson Velho P, Qazi F, Hassan S, et al. Efficacy of Radium-223 in Bone-metastatic Castrationresistant Prostate Cancer with and Without Homologous Repair Gene Defects. Eur Urol. 2019; 76(2):170−176. DOI:10.1016/j.eururo.2018.09.040.; Sutera P, Deek MP, Van der Eecken K, et al. Genomic biomarkers to guide precision radiotherapy in prostate cancer. Prostate. 2022; 82 Suppl 1(Suppl 1):S73− S85. DOI:10.1002/pros.24373.; Robinson D, Van Allen EM, Wu YM, et al. Integrative clinical genomics of advanced prostate cancer. Cell. 2015; 161(5):1215−1228. DOI:10.1016/j.cell.2015.05.001.; Cohen SA, Pritchard CC, Jarvik GP. Lynch Syndrome: From Screening to Diagnosis to Treatment in the Era of Modern Molecular Oncology. Annu Rev Genomics Hum Genet. 2019; 20:293−307. DOI:10.1146/annurev-genom-083118-015406.; Mitra AV, Bancroft EK, Barbachano Y, et al. Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int. 2011; 107(1):28−39. DOI:10.1111/j.1464410X.2010.09648.x.; Sokolova AO, Cheng HH. Genetic Testing in Prostate Cancer. Curr Oncol Rep. 2020; 22(1):5. DOI:10.1007/s11912-020-0863-6.; European Association of Urology. Guidelines 2020. In Russian [Европейская ассоциация урологов. Клинические рекомендации Европейской ассоциации урологов 2020].; Loeb S, Carter HB, Catalona WJ, et al. Baseline prostate-specific antigen testing at a young age. Eur Urol. 2012; 61(1):1−7. DOI:10.1016/j.eururo.2011.07.067.; Bancroft EK, Page EC, Castro E, et al. Targeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study. Eur Urol. 2014; 66(3):489−499. DOI:10.1016/j.eururo.2014.01.003.; Tang P, Sun L, Uhlman MA, et al. Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk. J Urol. 2010; 183(3):946−950. DOI:10.1016/j.juro.2009.11.021.; Vickers AJ, Ulmert D, Sjoberg DD, et al. Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40−55 and long term risk of metastasis: case-control study. BMJ. 2013; 346:f2023. DOI:10.1136/bmj.f2023.; Wyatt AW, Annala M, Aggarwal R, et al. Concordance of Circulating Tumor DNA and Matched Metastatic Tissue Biopsy in Prostate Cancer. J Natl Cancer Inst. 2017; 109(12):djx118. DOI:10.1093/jnci/djx118.; Sigorski D, Iżycka-Świeszewska E, Bodnar L. Poly(ADP-Ribose) Polymerase Inhibitors in Prostate Cancer: Molecular Mechanisms, and Preclinical and Clinical Data. Target Oncol. 2020; 15(6):709−722. DOI:10.1007/s11523-020-00756-4.; Bishoff JT, Freedland SJ, Gerber L, et al. Prognostic utility of the cell cycle progression score generated from biopsy in men treated with prostatectomy. J Urol. 2014; 192(2):409−414. DOI:10.1016/j.juro.2014.02.003.; Klein EA, Yousefi K, Haddad Z, et al. A genomic classifier improves prediction of metastatic disease within 5 years after surgery in node-negative high-risk prostate cancer patients managed by radical prostatectomy without adjuvant therapy. Eur Urol. 2015; 67(4):778−786. DOI:10.1016/j.eururo.2014.10.036.; Benjamin H, Tashzna J, Olamide O, et al. Association Between a 22-feature Genomic Classifier and Biopsy Gleason Upgrade During Active Surveillance for Prostate Cancer. Eur Urol Open Sci. 2022 Feb 11; 37:113−119. DOI:10.1016/j.euros.2022.01.008.; Geybels MS, Wright JL, Bibikova M, et al. Epigenetic signature of Gleason score and prostate cancer recurrence after radical prostatectomy. Clin Epigenetics. 2016; 8:97. DOI:10.1186/s13148-016-0260-z.; Covas Moschovas M, Chew C, Bhat S, et al. Association Between Oncotype DX Genomic Prostate Score and Adverse Tumor Pathology After Radical Prostatectomy. Eur Urol Focus. 2022; 8(2):418−424. DOI:10.1016/j.euf.2021.03.015.; https://transmed.almazovcentre.ru/jour/article/view/803

الاتاحة: https://transmed.almazovcentre.ru/jour/article/view/803
https://doi.org/10.18705/2311-4495-2023-10-4-322-331

المؤلفون: Angelika V. Timofeeva, Aleksandra V. Asaturova, Maya V. Sannikova, Grigory N. Khabas, Vitaliy V. Chagovets, Ivan S. Fedorov, Vladimir E. Frankevich, Gennady T. Sukhikh

المصدر: Life; Volume 12; Issue 12; Pages: 2017

مصطلحات موضوعية: miRNA, new-generation sequencing (NGS), quantitative RT-PCR, high-grade serous ovarian carcinoma (HGSOC), cytoreduction, response to chemotherapy, progesterone receptor

جغرافية الموضوع: agris

وصف الملف: application/pdf

Relation: Physiology and Pathology; https://dx.doi.org/10.3390/life12122017

الاتاحة: https://doi.org/10.3390/life12122017

المؤلفون: Buyuksimsek M, Togun M, Oguz Kara I, Bisgin A, Boga I, Tohumcuoglu M, Ogul A, Evren Yetisir A, Sahin B, Sumbul HE, Mirili C

المصدر: Balkan Journal of Medical Genetics, Vol 22, Iss 2, Pp 17-24 (2019)

مصطلحات موضوعية: liquid biopsy, new generation sequencing (ngs), non-small cell lung cancer (nsclc), Genetics, QH426-470

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1311-0160

URL الوصول: https://doaj.org/article/b8150cdb158a48dabd74479f1fe9f638

المؤلفون: Francesco Maroso, Celia Pérez de Gracia, David Iglesias, Asunción Cao, Seila Díaz, Antonio Villalba, Manuel Vera, Paulino Martínez

المصدر: Genes; Volume 10; Issue 10; Pages: 760

مصطلحات موضوعية: 2b–RAD, cockles, diagnostic SNPs, hybrids, New Generation Sequencing (NGS), SNaPshot, wildlife forensic

جغرافية الموضوع: agris

وصف الملف: application/pdf

Relation: Population and Evolutionary Genetics and Genomics; https://dx.doi.org/10.3390/genes10100760

الاتاحة: https://doi.org/10.3390/genes10100760

المؤلفون: Asunción Cao, Antonio Villalba, David Iglesias, Paulino Martínez, Francesco Maroso, Manuel Vera, Celia Pérez de Gracia, Seila Díaz

المساهمون: Universidade de Santiago de Compostela. Centro de Investigación en Medicina Molecular e Enfermidades Crónicas, Universidade de Santiago de Compostela. Departamento de Zooloxía, Xenética e Antropoloxía Física, Universidade de Santiago de Compostela. Instituto de Acuicultura

المصدر: Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname
Genes, Vol 10, Iss 10, p 760 (2019)

مصطلحات موضوعية: 0106 biological sciences, 0301 basic medicine, Cerastoderma edule, wildlife forensic, lcsh:QH426-470, Range (biology), Introgression, Zoology, Hybrids, 010603 evolutionary biology, 01 natural sciences, DNA sequencing, 03 medical and health sciences, New Generation Sequencing (NGS), SNaPshot, Genetics, Cockle, Genetics (clinical), new generation sequencing (ngs), Hybrid, 2b–RAD, Cockles, hybrids, biology, snapshot, Ribosomal RNA, biology.organism_classification, lcsh:Genetics, 030104 developmental biology, Diagnostic SNPs, cockles, diagnostic snps, Cerastoderma glaucum, Wildlife forensic, 2b–rad

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2de58b594ba0a544efd11f430fa4895b
https://hdl.handle.net/10347/21878

المؤلفون: Paolillo, Alini Trujillo UNIFESP

المساهمون: Toledo, Silvia Regina Caminada De UNIFESP, Universidade Federal de São Paulo

مصطلحات موضوعية: Osteosarcoma, Primary Culture, Gene Expression, New Generation Sequencing (NGS), Response To Treatment, Osteossarcoma, Cultura Primária, Expressão Gênica, Sequenciamento De Nova Geração (NGS), Resposta Ao Tratamento

وصف الملف: 185 p.

Relation: https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=9751367; https://repositorio.unifesp.br/xmlui/handle/11600/64325

الاتاحة: https://repositorio.unifesp.br/xmlui/handle/11600/64325
https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=9751367

المؤلفون: Piorkowski, Geraldine

المساهمون: Aix-Marseille, Lamballerie, Xavier de

المصدر: Theses.fr

مصطلحات موضوعية: Virus Ebola, Séquençage nouvelle génération (NGS), Modèle animal, Quasi species, Ebola virus, New generation sequencing (NGS), Non-Human primate model, envir, phil

Relation: 10670/1.mpkiit; http://www.theses.fr/2019AIXM0216

الاتاحة: http://www.theses.fr/2019AIXM0216

المؤلفون: Universidade de Santiago de Compostela. Centro de Investigación en Medicina Molecular e Enfermidades Crónicas, Universidade de Santiago de Compostela. Departamento de Zooloxía, Xenética e Antropoloxía Física, Universidade de Santiago de Compostela. Instituto de Acuicultura, Maroso, Francesco, Pérez de Gracia Pérez, Celia, Iglesias Estepa, David, Cao Hermida, María Asunción, Díaz Costas, Seila María, Villalba García, Antonio, Vera Rodríguez, Manuel, Martínez Portela, Paulino

مصطلحات الفهرس: 2b–RAD, Cockles, Diagnostic SNPs, Hybrids, New Generation Sequencing (NGS), SNaPshot, Wildlife forensic, journal article

URL: http://hdl.handle.net/10347/21878
https://doi.org/10.3390/genes10100760
https://doi.org/10.3390/genes10100760